Among active 13F managers last quarter, 2 opened and 3 added, while 3 reduced; the largest holder to move was Marshall Wace, LLP (−0.6%). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
31 tracked 13F filers disclose a position in ALGS as of the latest SEC 13F filings, a combined $15.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Deep Track Capital, LP | 444K | $3.3M | —Held | Q1 2026 | |
| 2 | Alyeska Investment Group, L.P. | 412K | $2.4M | —Held | Q2 2026 | |
| 3 | Marshall Wace, LLP | 267K | $2.0M | ▼−0.6% Reduced · −2K sh | Q1 2026 | |
| 4 | Bank Of America Corp | 230K | $1.7M | ▲18× Added · +217K sh | Q1 2026 | |
| 5 | Woodline Partners LP | 177K | $1.0M | —Held | Q2 2026 | |
| 6 | Vanguard Capital Management LLC | 176K | $1.0M | ▼−1.5% Reduced · −3K sh | Q2 2026 | |
| 7 | Renaissance Technologies LLC | 100K | $746K | ▲+18% Added · +15K sh | Q1 2026 | |
| 8 | Baker Bros. Advisors LP | 83K | $479K | —Held | Q2 2026 | |
| 9 | HHLR Advisors, LTD. | 76K | $440K | —Held | Q2 2026 | |
| 10 | LPL Financial LLC | 52K | $383K | ▼−22% Reduced · −15K sh | Q1 2026 | |
| 11 | Geode Capital Management, LLC | 47K | $272K | ▼−5.6% Reduced · −3K sh | Q2 2026 | |
| 12 | UBS Group AG | 37K | $275K | ▲102× Added · +37K sh | Q1 2026 | |
| 13 | BlackRock, Inc. | 30K | $175K | ▲+132% Added · +17K sh | Q2 2026 | |
| 14 | Vanguard Fiduciary Trust Co | 29K | $165K | ▲+0.6% Added · +175 sh | Q2 2026 | |
| 15 | Two Sigma Investments, LP | 23K | $172K | ▼−71% Reduced · −58K sh | Q1 2026 | |
| 16 | Verition Fund Management LLC | 19K | $109K | —Held | Q2 2026 | |
| 17 | XTX Topco Ltd | 14K | $105K | ▼−38% Reduced · −9K sh | Q1 2026 | |
| 18 | Trexquant Investment LP | 12K | $71K | ▲New +12K sh | Q2 2026 | |
| 19 | D. E. Shaw & Co., Inc. | 11K | $82K | ▲New +11K sh | Q1 2026 | |
| 20 | Rockefeller Capital Management L.P. | 10K | $74K | —Held | Q1 2026 | |
| 21 | Federation des caisses Desjardins du Quebec | 5K | $27K | ▲+389% Added · +4K sh | Q2 2026 | |
| 22 | Golden State Wealth Management, LLC | 3K | $15K | —Held | Q2 2026 | |
| 23 | Royal Bank Of Canada | 2K | $16K | —Held | Q1 2026 | |
| 24 | Wells Fargo & Company | 700 | $5K | ▼−53% Reduced · −800 sh | Q1 2026 | |
| 25 | JPMorgan Chase & Co | 674 | $4K | ▲+120% Added · +368 sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 2 funds opened a new position in ALGS and 3 added to an existing one, while 3 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Maze Therapeutics IncMAZE | 13 funds | $155.1M |
| Nvidia CorpNVDA | 12 funds | $9.8B |
| Insmed IncINSM | 12 funds | $2.0B |
| Intel CorpINTC | 12 funds | $1.7B |
| Texas Instruments IncTXN | 12 funds | $1.2B |
| Lumentum Holdings IncLITE | 12 funds | $1.1B |
| General ElectricGE | 12 funds | $881.0M |
| Axsome Therapeutics IncAXSM | 12 funds | $461.5M |
| Cytokinetics IncCYTK | 12 funds | $349.3M |
| Cogent Biosciences IncCOGT | 12 funds | $322.0M |
| Microsoft CorpMSFT | 11 funds | $5.6B |
| Alphabet Inc-CL AGOOGL | 11 funds | $5.2B |
Ranked by how many of ALGS's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ALGS.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Oct 25, 2023 | Nuechterlein Carole | Director, 10% Owner | Buy (P) | 7.9M | $6.0M |
| Oct 20, 2020 | Novo Holdings A/S | 10% Owner | Buy (P) | 200K | $3.0M |
| Oct 20, 2020 | Versant Venture Capital VI, L.P. | 10% Owner | Buy (P) | 200K | $3.0M |
| Oct 20, 2020 | Vivo Capital Surplus Fund VIII, L.P. | 10% Owner | Buy (P) 2 lots, same day | 550K | $8.3M |
| Oct 20, 2020 | Woiwode Thomas | Director | Buy (P) | 200K | $3.0M |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 10 | 8 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for ALGS
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ALGS/capital-change-brief"
Use Arkolith's capital_change_brief for ALGS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ALGS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.